<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05111015</url>
  </required_header>
  <id_info>
    <org_study_id>TRAC_AF Outcomes 2017</org_study_id>
    <nct_id>NCT05111015</nct_id>
  </id_info>
  <brief_title>Tracking Results of Ablations to Combat AF Registry</brief_title>
  <acronym>TRAC-AF</acronym>
  <official_title>A Multicenter Patient Registry for Outcomes From Comprehensive Ablation Treatments of Atrial Arrhythmias</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AtriCure, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AtriCure, Inc.</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a global retrospective and prospective, multicenter, observational patient registry&#xD;
      to record outcomes from patients undergoing ablations for the treatment of Atrial&#xD;
      Fibrillation.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">February 2013</start_date>
  <completion_date type="Anticipated">January 2027</completion_date>
  <primary_completion_date type="Anticipated">January 2027</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <target_duration>12 Months</target_duration>
  <primary_outcome>
    <measure>Long term effect of the ablation procedure</measure>
    <time_frame>6 months</time_frame>
    <description>Atrial Fibrillation lasting longer than 30 seconds as documented by long term event monitoring or identified during exam after a six month recovery period.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Safety of the ablation procedure</measure>
    <time_frame>1 year</time_frame>
    <description>Adverse events occurred during the operation or post-operation.</description>
  </primary_outcome>
  <enrollment type="Anticipated">5000</enrollment>
  <condition>Atrial Fibrillation</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AtriCure Isolator® Synergy™ Surgical Ablation System</intervention_name>
    <description>The AtriCure Isolator® Synergy™ Surgical Ablation System is used in the Maze IV procedure for the treatment of Atrial Fibrillation.</description>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AtriCure AtriClip® LAA Exclusion System</intervention_name>
    <description>The AtriCure AtriClip® LAA Exclusion System is used to exclude the Left Atrial Appendage.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The TRAC-AF registry eligibility is open to sites and physicians performing Maze IV&#xD;
        ablation procedures as treatments for patients diagnosed with paroxysmal, persistent or&#xD;
        long-standing persistent atrial fibrillation using AtriCure Isolator® Synergy™ Clamp System&#xD;
        and AtriCure AtriClip® LAA Exclusion System. Subjects must have been scheduled to undergo&#xD;
        or have undergone the ablation treatment and must meet all eligibility criteria in order&#xD;
        for their treatment and results to be considered for this registry.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient with a history of paroxysmal (intermittent), persistent or long-standing&#xD;
             persistent atrial fibrillation and who have undergone or will undergo ablation&#xD;
             treatment&#xD;
&#xD;
          -  Patient &gt;= 18 years of age&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subject is enrolled in a concurrent study that has not been approved for concurrent&#xD;
             enrollment by the global study manager&#xD;
&#xD;
          -  Subject with exclusion criteria required by FDA or local governance&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 28, 2021</study_first_submitted>
  <study_first_submitted_qc>October 28, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 8, 2021</study_first_posted>
  <last_update_submitted>October 28, 2021</last_update_submitted>
  <last_update_submitted_qc>October 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

